Press Releases & News
International Isotopes, Inc. Announces Fiscal Results for the Third Quarter and Nine Months Ended September 30, 2025
IDAHO FALLS, IDAHO, November 14, 2025. International Isotopes Inc. (OTCQB: INIS) (the “Company” or “INIS”) is pleased to announce its financial results for...
International Isotopes Announces Exclusive North American Distribution and Service Agreement with Globalsonics Research Pty Ltd.
IDAHO FALLS, Idaho & LANE COVE, Australia - October 23, 2025. International Isotopes, Inc. (“INIS”), a leading U.S. provider of medical isotopes and...
International Isotopes Inc. Appoints Dr. Duke W. Fu to Board of Directors
Idaho Falls, ID – October 22th, 2025 – International Isotopes Inc. (OTCQB: INIS) (“INIS” or the “Company”), a leading provider of radiopharmaceuticals,...
International Isotopes and AFR Submit NRC Consent Request for New Mexico License Transfer
Idaho Falls, ID – October 21st, 2025 – International Isotopes, Inc. (OTCQB: INIS) (“INIS” or the “Company”), together with American Fuel Resources LLC...
International Isotopes, Inc. Announces Financial Results for the Second Quarter of 2025
Sale of product for the first six months of 2025 increased 13.5% or $820,529 Net Income (Loss) the first six months of 2025 improved 29% to a loss of $273,479...
RadQual Has Gone to Space!
RadQual's custom Ba-133 sources for NASA's PADRE (Polarization and Directivity X-Ray Experiment), were launched aboard a SpaceX Falcon 9 rocket for...
International Isotopes to Distribute TerThera’s Terbium-161 (Tb-161) in the United States
Idaho Falls, Idaho, June 18th, 2025. International Isotopes Inc. (OTCQB: INIS), a leading supplier of radiopharmaceuticals, nuclear medicine products, and...
International Isotopes Inc. Announces Availability of Ytterbium-176 (Yb-176)
New Product Expands Support for Growing Radiopharmaceutical Market Idaho Falls, Idaho, June 2, 2025 – International Isotopes Inc. (OTCQB: INIS), is...
International Isotopes, Inc. Announces Financial Results for the First Quarter of 2025
Sale of product for first quarter increased 12% to $3.2 million. Nuclear Medicine Standards sale of product in the first quarter increased 73% to $1.3...
International Isotopes, Inc. Announces Fiscal Results for the Fourth Quarter and Fiscal Year 2024
Revenues for fourth quarter increased 24% to $3.9 million. Full year revenues increased by 13% to $13.9 million, a historical high. Net Income in the fourth...
International Isotopes, Inc. Expands Operational Footprint with Strategic Land Acquisition and Additional New Facility Lease Agreement
Idaho Falls, Idaho, January 13th, 2025. International Isotopes, Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”), is excited to announce...
International Isotopes, Inc. Announces the Amendment of the Acquisition of the AMICI, Inc. Product Line
IDAHO FALLS, IDAHO, January 9th, 2025. International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce...